Form 8-K ImmunoCellular Therapeut For: Aug 07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Immunocellular Therapeutics, Ltd. (IMUC) Tops Q2 EPS by 10c
August 8, 2014 8:12 AM EDTImmunocellular Therapeutics, Ltd. (NYSE: IMUC) reported Q2 EPS of $0.04, $0.10 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on Immunocellular Therapeutics, Ltd. (IMUC) click here.
... More